Insulet
PODD
$167.25
Share price
-0.01%
Change (1 day)
-47.53%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
P/S ratio for Insulet (PODD)
P/S ratio as of April 2024 (TTM): 6.90
According to Insulet's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.90158. At the end of 2023 the company had a P/S ratio of 8.93.
P/S ratio history for Insulet from 2007 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 8.93 | -43% |
| 2022 | 15.7 | -6.21% |
| 2021 | 16.7 | -10.38% |
| 2020 | 18.6 | 28.18% |
| 2019 | 14.5 | 74.59% |
| 2018 | 8.33 | -3.82% |
| 2017 | 8.66 | 46.83% |
| 2016 | 5.90 | -23.28% |
| 2015 | 7.69 | -14.43% |
| 2014 | 8.98 | 9.01% |
| 2013 | 8.24 | 69.7% |
| 2012 | 4.85 | -17.17% |
| 2011 | 5.86 | -19.31% |
| 2010 | 7.26 | -11.04% |
| 2009 | 8.16 | 48.78% |
| 2008 | 5.49 | -87.81% |
| 2007 | 45.0 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.87 | -43.86% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.65 | -32.56% | 🇺🇸 USA |
 Medtronic MDT | 3.34 | -51.61% | 🇮🇪 Ireland |
 Eli Lilly LLY | 20.8 | 201.04% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | 3.02 | -56.25% | 🇺🇸 USA |
 ICU Medical
ICUI | 1.05 | -84.72% | 🇺🇸 USA |
 DexCom DXCM | 14.3 | 106.64% | 🇺🇸 USA |